urinary disorders. They work by blocking acetylcholine, a neurotransmitter key for memory and learning. Studies show they increase the risk of dementia. For example, a University of Washington study followed more than 3,500 older adults for 10 years and found that those who regularly used anticholinergics had a 54% increased risk of developing dementia.
Common anticholinergics linked to cognitive decline include meclizine, scopolamine, biperiden, oxybutynin, and diphenhydramine. In contrast, others such as glycopyrronium and tiotropium have not shown these effects. Patients and physicians should carefully weigh the risks and